BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 10075964)

  • 1. Effect of long term simvastatin administration as an adjunct to ursodeoxycholic acid: evidence for a synergistic effect on biliary bile acid composition but not on serum lipids in humans.
    Lanzarotto F; Panarotto B; Sorbara R; Panteghini M; Pagani F; Sosta S; Lanzini A
    Gut; 1999 Apr; 44(4):552-6. PubMed ID: 10075964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol metabolism and serum and biliary noncholesterol sterols in gallstone patients during simvastatin and ursodeoxycholic acid treatments.
    Miettinen TE; Kiviluoto T; Taavitsainen M; Vuoristo M; Miettinen TA
    Hepatology; 1998 Mar; 27(3):649-55. PubMed ID: 9500689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of simvastatin, ursodeoxycholic acid and simvastatin plus ursodeoxycholic acid on biliary lipid secretion and cholic acid kinetics in nonfamilial hypercholesterolemia.
    Mazzella G; Parini P; Festi D; Bazzoli F; Aldini R; Roda A; Tonelli D; Cipolla A; Salzetta A; Roda E
    Hepatology; 1992 Jun; 15(6):1072-8. PubMed ID: 1592346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol metabolism in primary biliary cirrhosis during simvastatin and UDCA administration.
    Del Puppo M; Galli Kienle M; Crosignani A; Petroni ML; Amati B; Zuin M; Podda M
    J Lipid Res; 2001 Mar; 42(3):437-41. PubMed ID: 11254756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficiency of ursotherapy in cholesterol-associated pathology of the gallbladder].
    Il'chenko AA; Drozhzhina IuV
    Eksp Klin Gastroenterol; 2009; (8):96-101. PubMed ID: 20469685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of ursodeoxycholic acid combined with statins in hypercholesterolemia treatment: a prospective clinical trial].
    Cabezas Gelabert R
    Rev Clin Esp; 2004 Dec; 204(12):632-5. PubMed ID: 15710069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of ursodeoxycholic acid on serum and biliary noncholesterol sterols in patients with gallstones.
    Miettinen TE; Tarpila S; Gylling H
    Hepatology; 1997 Mar; 25(3):514-8. PubMed ID: 9049189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation.
    Podda M; Zuin M; Dioguardi ML; Festorazzi S; Dioguardi N
    Hepatology; 1982; 2(3):334-9. PubMed ID: 7076116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid.
    Stojakovic T; Putz-Bankuti C; Fauler G; Scharnagl H; Wagner M; Stadlbauer V; Gurakuqi G; Stauber RE; März W; Trauner M
    Hepatology; 2007 Sep; 46(3):776-84. PubMed ID: 17668874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ursodeoxycholic acid on hepatic LDL binding and uptake in dietary hypercholesterolemic hamsters.
    Ceryak S; Bouscarel B; Malavolti M; Robins SJ; Caslow KL; Fromm H
    Atherosclerosis; 2000 Nov; 153(1):59-67. PubMed ID: 11058700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis.
    Lindor KD; Lacerda MA; Jorgensen RA; DeSotel CK; Batta AK; Salen G; Dickson ER; Rossi SS; Hofmann AF
    Am J Gastroenterol; 1998 Sep; 93(9):1498-504. PubMed ID: 9732932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ursodeoxycholic acid on synthesis of cholesterol and bile acids in healthy subjects.
    Sauter GH; Thiessen K; Parhofer KG; Jüngst C; Fischer S; Jüngst D
    Digestion; 2004; 70(2):79-83. PubMed ID: 15375335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of combined treatment with pravastatin and ursodeoxycholic acid on hepatic cholesterol metabolism.
    Hillebrant CG; Nyberg B; Gustafsson U; Sahlin S; Björkhem I; Rudling M; Einarsson C
    Eur J Clin Invest; 2002 Jul; 32(7):528-34. PubMed ID: 12153554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sedimentable sterols in gallstone patients before and during ursodeoxycholic acid and simvastatin treatments.
    Miettinen TE; Vuoristo M
    Scand J Gastroenterol; 1998 Dec; 33(12):1297-302. PubMed ID: 9930394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis.
    Roda E; Mazzella G; Bazzoli F; Villanova N; Minutello A; Simoni P; Ronchi M; Poggi C; Festi D; Aldini R
    Dig Dis Sci; 1989 Dec; 34(12 Suppl):52S-58S. PubMed ID: 2598768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response.
    van de Meeberg PC; Wolfhagen FH; Van Berge-Henegouwen GP; Salemans JM; Tangerman A; van Buuren HR; van Hattum J; van Erpecum KJ
    J Hepatol; 1996 Dec; 25(6):887-94. PubMed ID: 9007717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pravastatin and ursodeoxycholic acid on cholesterol and bile acid metabolism in patients with cholesterol gallstones.
    Okamoto S; Nakano K; Kosahara K; Kishinaka M; Oda H; Ichimiya H; Chijiiwa K; Kuroki S
    J Gastroenterol; 1994 Feb; 29(1):47-55. PubMed ID: 8199696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis.
    Poupon RE; Ouguerram K; Chrétien Y; Verneau C; Eschwège E; Magot T; Poupon R
    Hepatology; 1993 Apr; 17(4):577-82. PubMed ID: 8477962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in biliary lipid secretion and cholic acid kinetics induced by diet, diet plus simvastatin and diet plus ursodeoxycholic acid in obese subjects.
    Mazzella G; Cipolla A; Villanova N; Polimeni C; Sipahi A; Parini P; Fusaroli P; Festi D; Roda E
    Ital J Gastroenterol; 1995; 27(8):441-5. PubMed ID: 8775472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid.
    Honda A; Ikegami T; Nakamuta M; Miyazaki T; Iwamoto J; Hirayama T; Saito Y; Takikawa H; Imawari M; Matsuzaki Y
    Hepatology; 2013 May; 57(5):1931-41. PubMed ID: 22911624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.